Patient motivation for participating in clinical trials for depression: Validation of the motivation for clinical trials inventory-depression

International Clinical Psychopharmacology

Volumn 25, Issue 1, 2010, Pages 7-16

  Andresen, Emily L ^a,b   Wilson, Kimberly A ^a   Castillo, Adelaida ^a   Koopman, Cheryl ^a  

^a STANFORD UNIVERSITY   (United States)

^b PALO ALTO UNIVERSITY   (United States)

Author keywords

Depression; Measure; Motivation; Randomized clinical trial; Recruitment

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTENT VALIDITY; DECISION MAKING; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; MOTIVATION FOR CLINICAL TRIALS INVENTORY DEPRESSION; PATIENT PARTICIPATION; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; DEPRESSION; EDUCATIONAL STATUS; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUBJECTS; SEX CHARACTERISTICS;

EID: 73449084047     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328332055c     Document Type: Article

References (51)

1. American Psychological Association Task Force on Psychological Intervention Guidelines (1995). Template for developing guidelines: interventions for mental disorders and psychosocial aspects of physical disorders. Washington, DC: American Psychological Association.
2. American Psychological Association Presidential Task Force on Evidence-Based Practice (2006). Evidence-based practice in psychology. Am Psychol 61:271-285.
3. Angst J, Bech P, Bruinvels J, Engel RR, Ferner U, Guelfi JD, et al. (1994). Report on the fifth consensus conference: methodology of long-term clinical trials in psychiatry. Pharmacopsychiatry 2:101-107.
4. Chambless DL, Hollon SD (1998). Defining empirically supported therapies. J Consult Clin Psychol 66:7-18.
5. Chang BH, Hendricks AM, Slawsky MT, Locastro JS (2004). Patient recruitment to a randomized clinical trial of behavioral therapy for chronic heart failure. BMC Med Res Methodol 4:8.
6. Charlson ME, Horwitz RI (1984). Applying results of randomised trials to clinical practice: impact of losses before randomisation. Br Med J (Clin Res Ed) 289:1281-1284.
7. Cooper-Patrick L, Powe NR, Jenckes MW, Gonzales JJ, Levine DM, Ford DE (1997). Identification of patient attitudes and preferences regarding treatment of depression. J Gen Intern Med 12:431-438.
8. Cunny KA, Miller HW (1994). Participation in clinical drug studies: motivations and barriers. Clin Ther 16:273-282.
9. Ellis PM (2000). Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol 11:939-945.
10. Everett BS (2004.) Overview. In: Machin D, Day S, Green S, editors. Textbook of clinical trials. West Sussex. England: Wiley; pp. 235-241.
11. Fredman L, Weissman MM, Leaf PJ, Bruce ML (1988). Social functioning in community residents with depression and other psychiatric disorders: results of the new haven epidemiological catchment area study. J Affect Dis 15:103-112.
12. Goldman LS, Nielsen NH, Champion HC (1999). Awareness, diagnosis, and treatment of depression. J Gen Intern Med 14:569-580.
13. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER (1993). The economic burden of depression in 1990. J Clin Psychiatry 54:405-418.
14. Grunfeld E, Zitzelsberger L, Coristine M, Aspelund F (2002). Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates. Cancer 95:1577-1583.
15. Halpern SD, Karlawish JHT, Casarett D, Berlin JA, Townsend RR, Asch DA (2003). Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency. Am Heart J 146:985-992.
16. Henzlova MJ, Blackburn GH, Bradley EJ, Rogers WJ (1994). Patient perception of a long-term clinical trial: experience using a close-out questionnaire in the studies of left ventricular dysfunction (SOLVD) trial. Control Clin Trials 15:284-293.
17. Hilsenroth MJ, Ackerman SJ, Blagys MD, Baity MR, Mooney MA (2003). Short-term psychodynamic psychotherapy for depression: an examination of statistical, clinically significant, and technique specific change. J Nerv Ment Dis 191:349-357.
18. Hirschfeld RMA, Montgomery SA, Keller MB, Kasper S, Schatzberg AF, Moller HJ, et al. (2000). Social functioning in depression: a review. J Clin Psychiatry 61:268-275.
19. Hollon SD, Jarrett RB, Nierenberg AA, Thase ME, Trivedi M, Rush AJ (2005). Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry 66:455-468.
20. Hunninghake DB, Darby CA, Probstfields JL (1987). Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials 8:6S-30S.
21. Israni AK, Halpern SD, McFadden C, Israni RK, Wasserstein A, Kobrin S, Berns JS (2004). Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis. Kidney Int 65:990-998.
22. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch Gen Psychiatry 51:8-19.
23. Lebacqz K (1980). Controlled clinical trials: some ethical issues. Control Clin Trials 1:29-36.
24. Lovato LC, Hill KH, Hertert S, Hunninghake DB, Probstfield JL (1997). Recruitment for controlled clinical trials: literature summary and annotated bibliography. Control Clin Trials 18:328-357. (Pubitemid 127738667)
25. Madsen SM, Mirza MR, Holm S, Hilsted KL, Kampmann K, Riis P (2002). Attitudes towards research amongst participants and nonparticipants. J Intern Med 251:156-168.
26. Markowitz JC (1999). Developments in interpersonal psychotherapy. Can J Psychiatry 44:556-561.
27. Mattson ME, Curb JD, McArdle R (1985). Participation in a clinical trial: the patients' point of view. Control Clin Trials 6:156-167.
28. Narushima K, Kosier JT, Robinson RG (2002). Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 190:296-303.
29. Nelson JC (1999). A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression. Biol Psychiatry 46:1301-1308.
30. Olfson M, Marcus SC, Druss B, Elinson L,Tanielian T, Pincus HA (2002). National trends in the outpatient treatment of depression. JAMA 287:203-209. (Pubitemid 34251945)
31. Roberts LW (2002). Informed consent and the capacity for voluntarism. Am J Psychiatry 159:705-712.
32. Roberts LW, Warner TD, Brody JL, Roberts B, Lauriello J, Lyketsos C (2002). Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: assessment of harm potential and factors influencing participati on decisions. Am J Psychiatry 159:573-584.
33. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R (1999). Barriers to participation in randomised controlled trials: a systematic review. J Clin Epid 52:1143-1156.
34. Rothwell PM (2005). External validity of randomised controlled trials: to whom do the results of this trial apply? Lancet. pp. 82-93.
35. Schatzberg AF (1998). Noradrenergic verses serotonergic antidepressants: Predictors of treatment response. J Clin Psychiatry 59 (Suppl 14):15-18.
36. Sclar DA, Robison LM, Skaer TL (2008). Ethnicity/race and the diagnosis of depression and use of antidepressants by adults in the United States. Int Clin Psychopharmacol 23:106-109.
37. Shumaker SA, Dugan E, Bowen DJ (2000). Enhancing adherence in randomized controlled clinical trials. Control Clin Trials 21:S226-S232.
38. Snowdon C, Garcia J, Elbourne D (1998). Reactions of participants to the results of a randomized controlled trial: exploratory study. Brit Med J 317:21-26.
39. Spilker B, Cramer JA (1992.) Perspectives of patients, physicians, and staff about recruitment. In: Spilker B, Cramer JA, editors. Patient recruitment in clinical trials. New York, NY: Raven Press, Ltd; pp. 24-38.
40. Szegedi A, Janse WT, van Willigenburg AP, van der Meulen E, Stassen HH, Thase ME (2009). Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry 70:344-353.
41. Tamminga CA, Nemeroff CB, Blakely RD, Brady L, Carter CS, Davis KL, et al. (2002). Developing novel treatment for mood disorders: accelerating discovery. Biol Psychiatry 52:589-609.
42. Van Schaik DJF, Klijn AFJ, van Hout HPJ, van Marwijk HWJ, Beekman ATF, de Haan M, van Dyck R (2004). Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 26:184-189.
43. Wang PS, Simon G, Kessler RC (2003). The economic burden of depression and the cost effectiveness of treatment. Int J Methods Psychiatr Res 12:22-33.
44. Warner TD, Roberts LW, Nguyen K (2003). Do psychiatrists understand research-related experiences, attitudes and motivations of schizophrenia study participants? Compr Psychiatry 44:227-233.
45. Wells KB (1999). Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 156:5-10.
46. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, et al. (1989). The functioning and well-being of depressed patients. Results from the medical outcome study. JAMA 262:914-919. (Pubitemid 19208948)
47. Williams JW, Mulrow CD, Chiquette E, Noel PH, Aguilar C, Cornell J (2002). A systematic review of newer pharmacotherapies for depression in adults: evidence report summary: clinical guideline, Part 2. Ann Intern Med 132:743-756.
48. Yuval R, Halon DA, Merdler A, Khader N, Karkabi B, Uziel K, Lewis BS (2000). Patient comprehension and reaction to participating in a double-blind randomized clinical trial (ISIS-4) in acute myocardial infarction. Arch Intern Med 160:1142-1146.
49. Yuval R, Halon DA, Lewis BS (2001). Patients' point of view in heart failure trials. JAMA 285:883-884.
50. Zimmerman M, Mattia JI, Posternak MA (2002). Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 159:469-473.
51. Zullino D, Conus P, Borgeat F, Bonsack C (2003). Readiness to participate in psychiatric research. Can J Psychiatry 48:480-484.